PANDOMEDX, INC.
Biotech · Private
PDMX1001 (niclosamide), a small-molecule inhibitor of androgen receptor variant 7 (AR-V7), combined with abiraterone for treatment of castration-resistant prostate cancer
- Grants
- $1.8M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2016201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A Phase Ib clinical trial with niclosamide plus abiraterone for Castration Resistant Prostate Cancer (CRPC) | $299,986 | |
| Federal grant | Department of Health and Human Services · Phase II · A Phase II trial of abiraterone in combination with PDMX1001 in enzalutamide-resistant prostate cancer | $754,319 | |
| Federal grant | Department of Health and Human Services · Phase II · A Phase II trial of abiraterone in combination with PDMX1001 in enzalutamide-resistant prostate cancer | $750,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1447 | BRAINSTORM THERAPEUTICS, INC. | — | — |
| 1448 | Peptilogics | — | $41M |
| 1449 | Thetis Pharmaceuticals LLC | — | $14M |
| 1450 | PANDOMEDX, INC. | — | — |
| 1451 | COMETA THERAPEUTICS INC | — | — |
| 1452 | ProPhase Labs, Inc. | — | $8.4M |
| 1453 | Surf Lakes Global, Inc. | — | $720K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.